Octreotide clinical trials: 71 trials
Page 2 of 2
- Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients.
NCT02235987 · Phase 2 · Completed
Posted results
- Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size
NCT02021942 · Phase 2 · Completed
Posted results
- Palliative Management of Inoperable Malignant Bowel Obstruction
NCT04027348 · Phase 2 · Terminated
Posted results
- Sandostatin for Patients With Androgen Independent Prostate Cancer
NCT00510224 · Phase 2 · Terminated
Posted results
- Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)
NCT02299089 · Phase 2 · Completed
Posted results
- The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics
NCT02217800 · Phase 2 · Completed
Posted results
- Octreotide for Management of Bronchorrhea in Mechanically Ventilated Patients
NCT02916433 · Phase 2 · Completed
Posted results
- Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
NCT00005906 · Phase 2 · Completed
Posted results
- Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas
NCT06865677 · Phase 2 · Terminated
Posted results
- P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome
NCT01886287 · Phase 2 · Terminated
Posted results
- Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.
NCT06085976 · Phase 2 · Status unknown
Linked paper with results
- Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients
NCT00088582 · Phase 2 · Completed
Linked paper with results
- Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults
NCT03520569 · Early phase 1 · Completed
Posted results
- Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD)
NCT01707225 · Phase 1 · Completed
Posted results
- Effects of Glucagon Administration on Energy Expenditure
NCT02237053 · Phase 1 · Completed
Linked paper with results
- Acromegaly Combination Treatment Study
NCT01538966 · Not applicable · Terminated
Posted results
- Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
NCT00399893 · Not applicable · Terminated
Posted results
- Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails
NCT02311608 · Phase not stated · Status unknown
Linked paper with results
- Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion
NCT02920567 · Not applicable · Status unknown
Linked paper with results
- Octreotide in the Prevention of Postoperative Complications After Pancreaticoduodenectomy
NCT02474914 · Not applicable · Completed
Linked paper with results
- Outcome of ADPKD With Octreotide LAR
NCT06193616 · Phase not stated · Active, not recruiting
Linked paper with results